1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Ventricular Dysfunction, Right: new trials by email Literature Review of Ventricular Dysfunction, Right trials Research Report on Ventricular Dysfunction, Right
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism Alteplase, Unfractionated heparin, Placebo - Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism | Phase 4 | Terminated | Victor Tapson, MD | 4 | 2019-07-25 | 2021-06-11 |
Heart Failure (1) · Pulmonary Embolism (1)
Cardiovascular Diseases (1) · Embolism (1) · Embolism and Thrombosis (1) · Heart Diseases (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Vascular Diseases (1) · Ventricular Dysfunction (1)
Heparin (1) · Tissue Plasminogen Activator (1) · apixaban (1)
United States (1)
Aaron S Weinberg, MD (1) · Victor F Tapson, MD (1)